Mark Gilham, VP, head of global advisory, Enable explains how pharmaceutical wholesalers are protecting profits with pricing and rebates amid supply chain disruptions.
Enable
Protecting profits amid supply chain disruptions
Mark Gilham, VP, head of global advisory, Enable explains how pharmaceutical wholesalers are protecting profits with pricing and rebates amid supply chain disruptions.
Published:
|
3 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.